期刊文献+
共找到4篇文章
< 1 >
每页显示 20 50 100
溃疡散治疗消化性溃疡98例 被引量:2
1
作者 刘力 范文涛 张瑞娜 《陕西中医》 北大核心 2007年第9期1134-1136,共3页
目的:观察溃疡散治疗消化性溃疡临床疗效。方法:将190例消化性溃疡患者随机分为治疗组98例,口服溃疡散;对照组92例,口服雷尼替丁,观察临床症状、溃疡愈合、幽门螺杆菌改善情况。结果:治疗组疗效总有效率87.8%,对照组总有效率79.3%,两组... 目的:观察溃疡散治疗消化性溃疡临床疗效。方法:将190例消化性溃疡患者随机分为治疗组98例,口服溃疡散;对照组92例,口服雷尼替丁,观察临床症状、溃疡愈合、幽门螺杆菌改善情况。结果:治疗组疗效总有效率87.8%,对照组总有效率79.3%,两组比较有显著性差异(P<0.05)。提示:溃疡散治疗消化性溃疡疗效显著,复发率低,安全可靠。 展开更多
关键词 消化性溃疡/中医药疗法 补气剂/治疗应用 活血剂/治疗应用 @溃疡散
下载PDF
如达溃疡散对幽门结扎法大鼠胃溃疡作用的实验研究 被引量:9
2
作者 杜锦辉 武聚星 《中国中医药科技》 CAS 2012年第3期220-221,234,共3页
目的:观察如达溃疡散对幽门结扎法大鼠胃溃疡的作用并探讨其作用机制。方法:采用幽门结扎法复制胃溃疡模型,将60只SD大鼠随机分为如达溃疡散高、中、低剂量组,奥美拉唑组和模型对照组,每组12只,各组给予相应处理15天后,观察大鼠溃疡指... 目的:观察如达溃疡散对幽门结扎法大鼠胃溃疡的作用并探讨其作用机制。方法:采用幽门结扎法复制胃溃疡模型,将60只SD大鼠随机分为如达溃疡散高、中、低剂量组,奥美拉唑组和模型对照组,每组12只,各组给予相应处理15天后,观察大鼠溃疡指数、炎症指数,测定胃游离黏液及血清表皮生长因子(EGF)、血清前列腺素E2(PGE2)含量。结果:与模型对照组比较,如达溃疡散各剂量组均能降低溃疡指数及炎症指数,减轻黏膜损伤程度,增加血清表皮生长因子、前列腺素E2的含量(P<0.01,或P<0.05);其低剂量组与奥美拉唑组比较,差异无统计学意义。结论:如达溃疡散可有效拮抗实验性胃溃疡的产生,作用机制可能与增加保护因子有关。 展开更多
关键词 溃疡/药物疗法 @如达溃疡/治疗应用 溃疡/病理学 蒙药 大鼠
下载PDF
敛酸生肌溃疡散联合西药治疗虚寒消化性溃疡随机平行对照研究 被引量:1
3
作者 吉文龙 《实用中医内科杂志》 2017年第1期57-58,67,共3页
[目的]观察敛酸生肌溃疡散联合西药治疗虚寒消化性溃疡疗效。[方法]使用随机平行对照方法,将76例门诊患者按就诊顺序编号方法简单随机分为两组。对照组38例阿莫西林1g/次,2次/d,口服;克拉霉素0.5g/次,2次/d,口服;硫糖铝1.0g/次,1次/d,... [目的]观察敛酸生肌溃疡散联合西药治疗虚寒消化性溃疡疗效。[方法]使用随机平行对照方法,将76例门诊患者按就诊顺序编号方法简单随机分为两组。对照组38例阿莫西林1g/次,2次/d,口服;克拉霉素0.5g/次,2次/d,口服;硫糖铝1.0g/次,1次/d,口服。治疗组38例敛酸生肌溃疡散(白及、白芍各15g,蒲公英、桂枝、三七冲服、红蔻仁、乌贼骨、砂仁各10g,生姜、大枣为引),1剂/d,水煎服300mL,早晚口服;西药治疗同对照组。连续治疗14d为1疗程。观测临床症状、不良反应。连续治疗2疗程(28d),判定疗效。随访6个月,观测复发率。[结果]治疗组痊愈25例,显效7例,有效4例,无效2例,总有效率94.74%;对照组痊愈16例,显效3例,有效7例,无效12例,总有效率68.42%;治疗组疗效优于对照组(P<0.05)。[结论]敛酸生肌溃疡散联合西药治疗虚寒消化性溃疡,疗效满意,无严重不良反应,值得推广。 展开更多
关键词 消化性溃疡 胃脘痛 虚寒 敛酸生肌溃疡 中西医结合治疗 随机平行对照研究
下载PDF
Jinhuang powder for the treatment of diabetic foot ulcers:an updated metaanalysis with power analysis and trial sequential analysis 被引量:1
4
作者 Li Ma Li-Juan Yi Xu Tian 《TMR Integrative Nursing》 2018年第4期178-185,共8页
Background:Traditional Chinese Medicines(TCM)had been indicated to benefit for the chronic non-infectious diseases,such as cancers,hypertension,primary dysmenorrheal,etc.Although randomized controlled trials(RCTs)had ... Background:Traditional Chinese Medicines(TCM)had been indicated to benefit for the chronic non-infectious diseases,such as cancers,hypertension,primary dysmenorrheal,etc.Although randomized controlled trials(RCTs)had been conducted,there was still the controversy on the efficacy of Jinhuang powder for diabetic foot ulcers(DFUs).Objective:This systematic review aimed to objectively evaluate the potential of Jinhuang powder for DFUs.Methods:Seven databases(CNKI,Chongqing VIP,Wanfang database,CBM,the Cochrane Library,PubMed and Web of Science)were searched to retrieve RCTs up to December,2016;and the relevant references of the eligible studies were screened.According to the eligible criteria,the literature was screened;data were extracted;and then the methodological quality was assessed.The meta-analysis,power analysis and trial sequential analysis(TSA)were performed by using Meta analyst software(version beta 3.13),Stata 12.0,Power and Precision statistical software package(Biostat)and TSA software(version0.9),respectively.Results:Finally,three RCTs with 198 participants were included.The results of meta-analysis showed that there were statistically significant differences between groups in(1)the cure rate(RR,1.25;95%CI.1.10to1.41;P=0.00)and(2)the wound healing time(SMD,-3.404;95%CI,-5.821 to -0.987;P=0.00).Three trials presented more than 80% power with 0.05α-errors in both outcomes and the power of two meta-analyses to pool different outcomes presented more than 95%.The TSA showed that the summary results were certain.Conclusion:The external application with Jinhuang powder was an effective and cost-effective therapy for DFUs.The power analysis and TSA showed that the efficacy of Jinhuang powder dressing for the treatment of DFUs is conclusive. 展开更多
关键词 Jinhuang powder Diabetic foot ulcers META-ANALYSIS Systematic review Trial sequential analysis
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部